Evidence. Care. Accountability.Contact the desk
Our standards

Research explained

BPC-157 after inferior caval vein ligation

The experiment does not establish thrombosis prevention or treatment in human patients.

On this page

Evidence dossier

The report behind the claim

The investigators reported attenuation of the ligation syndrome and altered venous bypass pathways. The experiment does not establish thrombosis prevention or treatment in human patients.

Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157.

Design
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Participants or model
Rats with an experimentally ligated inferior caval vein
Endpoint
Thrombosis, collateral flow, pressure, bleeding and molecular measures
Finding on record
The investigators reported attenuation of the ligation syndrome and altered venous bypass pathways.
Limits of inference
The experiment does not establish thrombosis prevention or treatment in human patients.
Read the publication

The experiment in view

The study used rats with an experimentally ligated inferior caval vein. Its principal measures were thrombosis, collateral flow, pressure, bleeding and molecular measures. The investigators reported attenuation of the ligation syndrome and altered venous bypass pathways.

Reading the result closely

A ligature stays in place, unlike a naturally forming clot with its own changing biology. That feature makes collateral-flow observations interesting but also limits translation. Bleeding and clotting measures need to be retained individually instead of being summarized as a universal normalizing effect.

The boundary of the finding

The experiment does not establish thrombosis prevention or treatment in human patients.

Related evidence, kept separate

BPC-157 after a surgical aortic anastomosis examines thrombus formation, limb function and muscle strength. Here, the measured endpoint was thrombosis, collateral flow, pressure, bleeding and molecular measures. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the What changes when a BPC-157 paper becomes a sales claim? appraisal.

On the record

The documents supporting this report.

  1. BPC-157 after inferior caval vein ligation — original indexed research

The continuing record

More from the report

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review